EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudieOpen Access

Cryobiopsy vs Forceps for Bronchoscopic Lung Biopsy

Jeffrey Thiboutot, Christopher M Kapp, Peter Illei, Scott Shofer, Christopher R Gilbert, David DiBardino, Andrew DeMaio, Sonali Sethi, Momen M Wahidi, Bryan S Benn, Colin Gillespie, Cristina Salmon und 16 weitere

JAMA · 16.06.2026 · 335 (23) · 2038

DOI: 10.1001/jama.2026.7908 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA, erschienen am 16.06.2026. Verfasst von Jeffrey Thiboutot und 27 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland. Hauptthemen laut MEDLINE: Bronchoscopy, Lung, Lung Neoplasms, Surgical Instruments. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Bronchoscopic biopsy is conventionally performed with forceps, which can result in small specimen sizes and poor specimen quality due to crush artifact. Cryoprobe use localizes freezing at the probe tip, enabling retrieval of larger, more intact biopsy specimens.

Objective

To evaluate the diagnostic yield of a 1.1-mm cryoprobe for transbronchial biopsy. Design, Setting, and Participants This open-label, outcome assessor–masked, multicenter randomized clinical trial included 500 patients aged 18 years or older scheduled to undergo transbronchial biopsy for lung nodules or masses, lung transplant, or diffuse parenchymal lung disease. The trial was conducted in 9 US medical centers and enrolled patients between February 27, 2023, and September 11, 2024. The date of last follow-up was October 12, 2024.

Intervention

Patients were randomized 1:1 to transbronchial biopsy using a 1.1-mm cryoprobe (n = 250) or 2.0-mm forceps (n = 250). Main Outcomes and Measures The primary outcome was diagnostic yield, defined as the percentage of patients for whom the transbronchial biopsy sample led to a specific diagnosis based on histologic examination. Of the 8 prespecified secondary analyses, key secondary analyses were the diagnostic yield for each of the 3 conditions (lung nodules or masses, lung transplant, and diffuse parenchymal lung disease) and complication rates.

Results

Of 774 patients assessed for eligibility, 609 provided consent, 500 were randomized, and 490 were included in the primary analysis; the mean age was 62.6 years (SD, 12.7 years) and 252 of 500 (50.4%) were male. The primary outcome of diagnostic yield was significantly higher in patients randomized to transbronchial biopsy with cryoprobes vs forceps (217 of 245 [88.6%] vs 193 of 245 [78.8%]; absolute difference, 9.8%; 95% CI, 3.3%-16.3%; P = .003). For the key secondary analyses, compared with that of forceps, the diagnostic yield of cryoprobes was significantly higher among patients with pulmonary nodules or masses (79 of 95 [83.2%] vs 68 of 97 [70.1%]; absolute difference, 13.1%; 95% CI, 1.0%-24.6%; P = .04) and lung transplant (120 of 125 [96.0%] vs 110 of 124 [88.7%]; absolute difference, 7.3%; 95% CI, 0.6%-14.4%; P = .03) but did not differ significantly in diffuse parenchymal lung disease (18 of 25 [72.0%] vs 15 of 24 [62.5%]; absolute difference, 9.5%; 95% CI, −16.0% to 33.6%; P = .55). For the secondary safety analysis, there were 4 pneumothoraces requiring chest tube placement in the forceps group (1.6%) vs none in the cryoprobe group; no patients experienced significant bleeding or respiratory failure events. Conclusions and Relevance Transbronchial lung biopsy performed with a 1.1-mm cryoprobe had a significantly higher diagnostic yield compared with 2.0-mm forceps in a group of patients with lung nodules or masses, lung transplant, and diffuse parenchymal lung disease. Trial Registration ClinicalTrials.gov Identifier: NCT05751278

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BronchoscopyLungLung NeoplasmsSurgical InstrumentsLung Diseases, InterstitialAgedFemaleHumansMaleMiddle AgedBiopsyLung TransplantationPneumothoraxPostoperative ComplicationsFollow-Up StudiesTreatment Outcome

Autor:innen und Institutionen

  • Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland.
  • Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago, Illinois.
  • Department of Pathology, Johns Hopkins University, Baltimore, Maryland.
  • Division of Pulmonary and Critical Care Medicine, Duke University, Durham, North Carolina.
  • Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston.
  • Division of Pulmonary and Critical Care Medicine, University of Pennsylvania, Philadelphia.

Förderung

  • NCI NIH HHS

Zitieren

APA

Thiboutot, J., Kapp, C. M., Illei, P., Shofer, S., Gilbert, C. R., DiBardino, D., DeMaio, A., Sethi, S., Wahidi, M. M., Benn, B. S., Gillespie, C., Salmon, C., Angel, L., Sachdeva, A., Holden, V. K., Paez, R., Duke, J. D., Lentz, R. J., Vachani, A., …, & Interventional Pulmonary Outcomes Group (2026). Cryobiopsy vs Forceps for Bronchoscopic Lung Biopsy. JAMA, 335(23), 2038. https://doi.org/10.1001/jama.2026.7908

Vancouver

Thiboutot J, Kapp CM, Illei P, Shofer S, Gilbert CR, DiBardino D, et al. Cryobiopsy vs Forceps for Bronchoscopic Lung Biopsy. JAMA. 2026;335(23):2038. doi:10.1001/jama.2026.7908

BibTeX
@article{Thiboutot2026,
  author = {Thiboutot, Jeffrey and Kapp, Christopher M and Illei, Peter and Shofer, Scott and Gilbert, Christopher R and DiBardino, David and DeMaio, Andrew and Sethi, Sonali and Wahidi, Momen M and Benn, Bryan S and Gillespie, Colin and Salmon, Cristina and Angel, Luis and Sachdeva, Ashutosh and Holden, Van K and Paez, Rafael and Duke, Jennifer D and Lentz, Robert J and Vachani, Anil and Pastis, Nicholas and Molena, Daniela and Tackett, Sean and Jones, Miranda R and Rahman, Najib M and Silvestri, Gerard and Maldonado, Fabien and Yarmus, Lonny and Interventional Pulmonary Outcomes Group, Interventional Pulmonary Outcomes Group},
  title = {Cryobiopsy vs Forceps for Bronchoscopic Lung Biopsy},
  journal = {JAMA},
  year = {2026},
  volume = {335},
  number = {23},
  pages = {2038},
  doi = {10.1001/jama.2026.7908}
}
Kostenlos starten →